OncoCyte (NASDAQ:OCX) Now Covered by Lake Street Capital
Lake Street Capital initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report released on Friday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $5.00 target price on the stock. Other research analysts also recently issued reports about the stock. Stephens restated an “equal weight” rating and set […]
Lake Street Capital initiated coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report released on Friday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $5.00 target price on the stock. Other research analysts also recently issued reports about the stock. Stephens restated an “equal weight” rating and set […]
